Flow Cytometry-Based Measurable Residual Disease in Adults with High-Risk Acute Leukemia after Transplantation: is There an Optimal Timepoint?
Transplantation and cellular therapy(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined